Settings. Our codes were written in Scala and compiled under Simple Build Tool (SBT). The programs were run on Mac OS. We test the effectiveness of our implementation in various aspects. If not mentioned explicitly, we adopt the following default settings. We report macroaveraged F1 measures, which were further averaged by ten-fold cross validations. We consider both “Bernoulli” and “Multinomia...

1 Cooksey D. A review of UK health research funding. December, 2006. http://www.hm-treasury.gov.uk/media/56F/62/pbr06_cooksey_fi nal_ report_636.pdf (accessed March 29, 2007). 2 The Lancet. Reorganising research in the UK. Lancet 2006; 368: 2105. 3 Littman BH, Di Mario L, Plebani M, Marincola FM. What’s next in translational medicine? Clin Sci (Lond) 2007; 112: 217–27. 4 Department of Health. B...

http://bjo.bmj.com/content/95/2/294.full.html Updated information and services can be found at: These include: References http://bjo.bmj.com/content/95/2/294.full.html#ref-list-1 This article cites 4 articles, 1 of which can be accessed free at: service Email alerting box at the top right corner of the online article. Receive free email alerts when new articles cite this article. Sign up in the...

clicking here. colleagues, clients, or customers by , you can order high-quality copies for your If you wish to distribute this article to others here. following the guidelines can be obtained by Permission to republish or repurpose articles or portions of articles ): June 11, 2012 www.sciencemag.org (this information is current as of The following resources related to this article are availa...

Celestino Santos-Buelga 1,* and Arturo San Feliciano 2 1 Grupo de Investigación en Polifenoles (GIP-USAL), Universidad de Salamanca, Facultad de Farmacia, Campus Miguel de Unamuno, E-37007 Salamanca, Spain 2 Grupo de Diseño y Obtención de Moléculas Bioactivas (DOMOBIO-USAL), Universidad de Salamanca, Facultad de Farmacia, CIETUS, IBSAL, AFARCyL, Campus Miguel de Unamuno, E-37007 Salamanca, Spai...

OBJECTIVE To compare the intelligence quotient (IQ) of patients with thalassemia major (TM) to that of normal children. METHODS We conducted the study in April and May 2002 on 294 homozygote beta-thalassemia patients, (157 male and 137 female, mean age of 13.2 years; range, 9-18 years). These 294 patients were randomly selected from the 984 TM patients who routinely refer to Shiraz Cooley's M...